How to build and implement an eQMS: efficiency, compliance and data integrity – Register to webinar

News

GxpManager will present its Digitalization Solutions at the Swiss Biotech Day 2024 in Basel

GxpManager will be participating in the Swiss Biotech Day exhibition, which will take place on April 22nd and 23rd in Basel, Switzerland. Visit booth 70 to learn more about how our compliance-focused digitalization solutions revolutionize the biotechnology sector. Marc and Farida will be there to welcome you.

GxpManager at the Swiss Biotech Day

Swiss Biotech Day

The Swiss Biotech Day is a leading conference in European biotechnology, attracting professionals from the global life sciences community. This year, the emphasis is on providing a platform for networking, engaging in discussions, and exploring advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing. Attendees will have the opportunity to meet over 1,800 senior experts from the life science industry.

Compliant digitalization solutions for biotech companies.

Our participation in the exhibition will allow us to showcase our digitalization solutions designed specifically to streamline the collection, management, and analysis of critical data in the biotechnology domain. GxpManager helps companies achieve 100% compliance with regulations by offering digitalization of Excel files and paper forms.

At GxpManager, we strongly emphasize a user-centric approach with direct modeling with the client, enabling time and cost savings for all businesses. Additionally, our pre-validated platform allows for quick and easy implementation.

In addition, GxpManager offers pre-packaged and customizable applications such as Quality Management Systems, audit management, risk analysis, and much more to enable biotech companies to remain competitive in an ever-evolving regulatory environment.

Booth 70 is the place to be

the GxpManager Team

Farida

The GxpManager team

Marc

We look forward to meeting you in Basel on April 22nd and 23rd, 2024, to share our expertise and discover how GxpManager can meet your digitalization needs in the biotechnology sector.

Other news

News
Barriers to digitalization: regulatory constraints

regulatory standards represent a significant obstacle to adopting new technologies; however, digitization of business processes are becoming essential to ensure regulatory compliance for companies subject to stringent regulations.

Learn more
News
GxpManager, a leader in the digitalization of critical data, is participating in Medi’Nov 2024!

Whether you are a SME, a startup, a laboratory, a research and development center... our team is here to support you in transitioning.

Learn more
News
GxpManager at Forum Labo Lyon 2024: An Alliance for Laboratory Excellence

GxpManager platform offers a comprehensive solution to address laboratories' complex regulatory compliance challenges.

Learn more
News
Overcoming Financial Barriers to Digital Transformation: Investing in the Future

a significant obstacle often hinders companies' digitalization : the costs associated with implementing compliant digital solutions

Learn more
News
2024 upcoming exhibition

GxpManager will participate at many exhibitions in 2024

Learn more
News
Barriers to Digitalization: Fear of Change.

The digital transformation of companies faces a number of obstacles that are slowing down its adoption, despite its benefits.

Learn more
News
GxpManager Joins PMT Innovation, a Catalyst for Innovation and Growth

This membership marks a significant step in our commitment to innovation and the development of our company.

Learn more
News
The Expert in Digitizing Critical Data

A medical device's risk analysis is an essential step in ensuring that it complies with current regulations and is safe for users. In this field, digitizing critical data helps ensure data compliance, safety, and reliability.

Learn more
News
GxpManager: Recognized Vendor in Gartner’s Hype Cycle for Quality by Design

Quality by Design (QbD) has emerged as a critical framework in product development and quality assurance. Its systematic approach, rooted in science and quality risk management, has garnered significant industry attention.

Learn more